Inactive Instrument

Company BTG

Equities

GB0001001592

Pharmaceuticals

Business Summary

BTG plc is medical device development and healthcare service provider. It provides Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care and licensing business. It operates through three segments: Interventional Medicine, Pharmaceuticals and Licensing. The Interventional Medicine segment includes oncology, vascular and pulmonology. The segment's products include Beads, TheraSphere, EkoSonic, Varithena and PneumRx Coils for use in the treatment of liver tumors, blood clots, varicose veins and advanced emphysema. The Pharmaceuticals segment includes CroFab, DigiFab, Voraxaze and Vistogard products for use in the treatment of crotalid envenomation, digoxin toxicity, high-dose methotrexate toxicity and 5-fluorouracil toxicity. The Licensing segment includes Zytiga, Two-Part Hip Cup and Lemtrada products for use in the treatment of advanced prostate cancer, hip replacement and multiple sclerosis.

Managers

Managers TitleAgeSince
Director/Board Member 54 19-08-18

Members of the board

Members of the board TitleAgeSince
Director/Board Member 54 19-08-18
Director/Board Member 50 20-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 388,257,291 376,392,830 ( 96.94 %) 0 96.94 %

Company contact information

BTG Ltd.

Chapman House Farnham Business Park

GU9 8QL, Farnham

+

http://www.btgplc.com
address BTG

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Miscellaneous